Thanks, pierre and kadaicher.
I believe ASCO titles (not abstracts) will be released on Monday, April 20, 2015, if my notes are correct. Anybody?
Also, I'm not sure, but I seem to remember 5:00 p.m. Eastern?
It means lower fees for Asterias and also, because the stock sales are stopped and started at Asterias' discretion, it allows the company to take advantage of positive news and stock price strength to raise more money.
MLV, also, has given this company a vote of confidence.
"The further Prana can advance th drug, the more it is worth in a partnership negotiation. It is all about eliminating risk for the pharma."
Precisely right, kad, and it will not take much more information before Prana is worth a WHOLE LOT more. JMHO, of course.